Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology
2019
A-395-19; A-396-19; A-397-19
Pending
Biosimilars
Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation
The decision is reported
here.
Meet the team
![Warren Sprigings](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b602718f3580ecb0cc1e_warren-bw-min.jpg)
Warren Sprigings
Partner
![Nathaniel Dillonsmith](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bab4006d422e2353fe2b_nathaniel-bw-min.jpeg)
Nathaniel Dillonsmith
Associate